Pancreatic Cancer Research

ResearcherNanjing General Hospital of Nanjing Military CommandActive in the last 2 years

Rongxi Shen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5723-1876; OpenAlex author ID A5109701449. Sources: OpenAlex.

Their work

Papers
5 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 5

  1. METTL3 promotes pancreatic cancer immune escape by m6A modification of lncRNA AFAP1-AS1 to enhance EGR2 stability. First author DOI 10.1186/s40001-026-03963-3↗
  2. Pancreatic Cancer-Derived Extracellular Vesicles Enriched with miR-223-5p Promote Skeletal Muscle Wasting Associated with Cachexia. First author DOI 10.1002/advs.202504064↗
  3. IND-Enabling Studies for a TCR-T Targeting a Pancreatic Cancer KRASG12V Mutation. Co-author DOI 10.1158/1078-0432.ccr-24-3086↗
  4. Combining single-cell and bulk RNA sequencing, NK cell marker genes reveal a prognostic and immune status in pancreatic ductal adenocarcinoma. First author DOI 10.1038/s41598-024-65917-1↗
  5. Long Noncoding RNA CERS6-AS1 Accelerates the Proliferation and Migration of Pancreatic Cancer Cells by Sequestering MicroRNA-15a-5p and MicroRNA-6838-5p and Mo… Co-author DOI 10.1097/mpa.0000000000001806↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Daojun Zhu · 2 shared papers, 2021–2026 · strength 0.67
  2. Xinbo Wang · 3 shared papers, 2021–2025 · strength 0.63
  3. Min Li · 1 shared paper, 2026 · strength 0.50
  4. Yonghao Ouyang · 2 shared papers, 2024–2025 · strength 0.41
  5. Sizhen Wang · 2 shared papers, 2021–2025 · strength 0.36
  6. Xinying Wang · 1 shared paper, 2025 · strength 0.27
  7. Kangjing Xu · 1 shared paper, 2025 · strength 0.27
  8. Xin Chen · 1 shared paper, 2024 · strength 0.22
  9. Hong‐Ming Hu · 1 shared paper, 2025 · strength 0.19
  10. Yimin Chen · 1 shared paper, 2025 · strength 0.19
  11. Min Li · 1 shared paper, 2021 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.